Virogin Company

They are dedicated to developing the next generation of oncolytic virus (OV) therapeutics using their novel Synerlytic™ technical platform for improved cancer treatment. By exploring innovative approaches to immunotherapy, Virogin is committed to becoming a world leader in the field of immuno-oncology.

Funding Status: N/A
Headquarters: Shenzhen, Guangdong, China
Founded Date: 2015
Investor Type: Undisclosed
Investment Stage: Venture
Technology: Drug Design
Employee Number: Undisclosed
Number Of Exists: 1
Industry: Drug Discovery